Citation

M Nunes, S Kim, B Zeldow, A Violari, S Dittmer, H Cassim, T Thomas, N van Niekerk, M Cotton, C Mitchell, P Adrian, S Madhi on behalf of the P1041 team. Streptococcus pneumoniae colonization in pneumococcal vaccine-naïve HIV-exposed infected and -uninfected South African children. Medicine. 2020 Feb 19; 99(9):e19353. PMID: 32118776; PMCID: PMC7478396.

Citation

Patience Atuhaire, Sean S Brummel, Blandina Theophil Mmbaga, Konstantia Angelidou, Lee Fairlie, Avy Violari, Gerhard Theron, Cornelius Mukuzunga, Sajeeda Mawlana, Mwangelwa Mubiana-Mbewe, Megeshinee Naidoo, Bonus Makanani, Patricia Mandima, Teacler Nematadzira, Nishi Suryavanshi, Tapiwa Mbengeranwa, Amy Lofits, Michael Basar, Katie McCarthy, Judith S Currier, Mary Glenn Fowler, 1077BF/1077FF PROMISE Team. The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial. PLoS One. 2020 Jan 30; 15(1):e0228003. PMID: 31999753; PMCID: PMC6992010.

Citation

E McFarland, R Karron, P Muresan, C Cunningham, J Libous, C Perlowski, B Thumar, D Gnanashanmugam, J Moye, E Schappell, E Barr, V Rexroad, L Fearn, S Spector, M Aziz, M Cielo, C Beneri, A Wiznia, C Luongo, P Collins, U Buchholz, IMPAACT 2011 Study Team. Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children. Journal of Infectious Diseases. 2020 Feb 03; 221(4):534-543. PMID: 31758177; PMCID: PMC6996856.

Citation

Jim Aizire, Kristina Brooks, Mark Mirochnick, Patricia M Flynn, Kevin Butler, Jennifer J Kiser, George K Siberry, Terry Fenton, Mae Cababasay, Mary G Fowler, PROMISE Study Team. Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial. Journal of Acquired Immune Deficiency Syndromes. 2020 Feb 01; 83(2):173-180. PMID: 31929405; PMCID: PMC409985.

Citation

D Yin, C Ludema, S Cole, C Golin, W Miller, M Warshaw, R McKinney ; on behalf of the PENPACT-1 (PENTA 9 / PACTG 390) Study Team. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLoS One. 2020 Nov 23; 15(11):e0242405. PMID: 33226999; PMCID: PMC7682873.

Citation

Diana Clarke, Edward Acosta, Mae Cababasay, Jiajia Wang, Anne Chain, Hedy Teppler, Stephanie Popson, Bobbie Graham, Betsy Smith, Rohan Hazra, Kat Calabrese, Yvonne Bryson, Stephen Spector, Jos Lommerse, Mark Mirochnick, IMPAACT P1110 Protocol Team. Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1-Exposed Neonates at Risk of Infection (IMPAACT P1110). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 2020 May 01; 84(1):70-7. PMID: 31913995; PMCID: PMC144886.

Citation

Ahizechukwu C Eke, Jiajia Wang , Khadija Amin, David E Shapiro , Alice Stek , Elizabeth Smith, Nahida Chakhtoura, Michael Basar, Kathleen George, Katherine M Knapp, Esaú C João, Kittipong Rungruengthanakit , Edmund Capparelli, Sandra Burchett , Mark Mirochnick , Brookie M Best, P1026s Protocol Team. Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy. Antimicrobial Agents and Chemotherapy. 2020 Mar 24; 64(4):e02260-19. PMID: 32015036; PMCID: PMC7179299.

Citation

Esaú C João, R Leavitt Morrison, David E Shapiro, Nahida Chakhtoura, Maria Isabel S Gouvèa, Maria de Lourdes B Teixeira, Trevon L Fuller, Blandina T Mmbaga, James S Ngocho, Boniface N Njau, Avy Violari, Ruth Mathiba, Zaakirah Essack , Jose Henrique S Pilotto, Luis Felipe Moreira, Maria Jose Rolon, Pedro Cahn, Sinart Prommas , Timothy R Cressey, Kulkanya Chokephaibulkit, Peerawong Werarak, Lauren Laimon, Roslyn Hennessy , Lisa M Frenkel , Patricia Anthony, Brookie M Best, George K Siberry, Mark Mirochnick. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial. Lancet HIV. 2020 May 01; 7(5):e322-e331. PMID: 32386720; PMCID: PMC7323582.

Citation

Elizabeth J. McFarland, Ruth A. Karron, Petronella Muresan, Coleen K. Cunningham, Charlotte Perlowski, Jennifer Libous, Jennifer Oliva, Patrick Jean-Philippe, Jack Moye Jr, Elizabeth Schappell, Emily Barr, Vivian Rexroad, Laura Fearn, Mikhaela Cielo, Andrew Wiznia, Jaime G. Deville, Lijuan Yang, Cindy Luongo, Peter L.Collins, Ursula J. Buchholz. Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with small hydrophobic non-coding region is highly immunogenic in children. Journal of Infectious Diseases. 2020 Jun 11; 221(12):2050-2059. PMID: 32006006; PMCID: PMC7289559.

Citation

Denise L Jacobson, Jane C Lindsey, Catherine Gordon, Rohan Hazra, Hans Spiegel, Flavia Ferreira, Fabiana R Amaral, Jesica Pagano-Therrien, Aditya Gaur, Kathy George, jane Benson, George K Siberry. Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for Age. Clinical Infectious Diseases. 2020 Aug 22; 71(5):1281-1288. PMID: 31573608; PMCID: PMC7442851.